Kiran Elite: Motorized Digital C-Arm for Hybrid OR! Kumar Jeetendra | May 12, 2020 With a significant rise in minimally invasive surgery procedures, there is a pressing need for an advanced medical imaging system. Kiran Medical Systems, the radiology division of Trivitron Healthcare, launched Elite – a Motorized Digital C-Arm that is a precise & efficient imaging system making it a perfect fit for Hybrid OR. Elite features Flat …
200 ventilators ‘gave’ by Trump to cost India $2.6 million: Report Kumar Jeetendra | May 18, 2020 The assessed cost of every versatile ventilator “gave” by the United States to India is about Rs 10 lakh. The US will carrier 200 such portable ventilators, According to a report by the Hindustan Times. An administration official told the paper that the transfer will show up by May-end or most recent by early June. …
Amid Covid-19 Lockdown, Doctors at Aster CMI Hospital Conduct Life Saving Liver Transplant of a 4-year-old child Kumar Jeetendra | May 29, 2020 Bangalore, May 28, 2020: At a time when healthcare workers across the country are donning protective gear to deal with the COVID-19 crisis, a team of medical staffs at Aster CMI Hospital suited up on April 13, 2020 to deliver a life-saving liver transplant for 4-year-old Raghavi from Vellore who was suffering from advanced liver …
Novel neuroimaging investigation on dissociative side effects uncovers wounds of youth Trauma Kumar Jeetendra | September 27, 2020 Trauma can cause dissociative side effect in individuals -, for example, encountering amnesia, an out-of-body understanding, feeling genuinely numb – which may help individuals adapt. Experiencing these symptoms intensely or for a long time, however, can negatively impact an individual’s ability to function. A group drove by examiners at McLean Hospital has now discovered that …
High-dosage favipiravir ‘strong’ against COVID-19, HCQ totally incapable: Study Kumar Jeetendra | October 11, 2020 Research conducted at the KU Leuven Rega Institute in Belgium has found that the antimalarial drug hydroxychloroquine (HCQ) doesn’t limit the multiplication of the novel coronavirus. However, a very high dose of the flu drug favipiravir does have antiviral efficacy, according to their results. The researchers gave the hamsters either hydroxychloroquine or favipiravir for four …
Age may not add to COVID-19 contamination risk: Study Kumar Jeetendra | October 13, 2020 The age of a person may not decide how likely they are infected by SARS-CoV-2, which induces COVID-19, according to a study which found that growth of symptoms, severity of the disease, and mortality are age-dependent. It’s been shown that elderly individuals disproportionately develop acute symptoms of COVID-19 and show higher mortality. Scientists, including those …
China’s Sinovac is sheltered, says Brazil’s leading research organization Kumar Jeetendra | October 20, 2020 São Paulo’s Butantan Institute, one of Brazil’s leading biomedical research centers, which is carrying out the Stage 3 tests, said the two-dose vaccine, called CoronaVac, was secure in a trial thus far involving 9,000 volunteers. But Butantan manager Dimas Covas said data on how effective the vaccine is will not be published until the trial …
Poor intimate hygiene linked to being one of the biggest causes of cervical cancer Kumar Jeetendra | October 22, 2020 Cervical cancer is becoming one of the emerging health burdens for womanhood. Cervical cancer is the fourth most common type of cancer for women worldwide, but also one of the most preventable types of cancer. Most cervical cancer cases are caused by the sexually transmitted human papilloma virus (HPV). According to the data released in 2018 by the HPV Centre, in India, cervical …
WHO-drove COVID-19 medication plot copies down on antibodies, steroids and disregards remdesivir Kumar Jeetendra | November 6, 2020 A World Health Organization-led scheme to provide COVID-19 drugs to poor countries is gambling on experimental monoclonal antibody treatments and steroids but is shunning Gilead’s remdesivir blockbuster therapy, an internal document shows. The WHO draft document, seen by Reuters and dated October 30, states the priorities are to secure monoclonal antibodies in a tight market …
India sees early vaccine dispatch as AstraZeneca conveyances run late Kumar Jeetendra | November 6, 2020 A vaccine is seen as the world’s best bet for taming a virus that has infected more than 48 million people, led to over 1.2 million deaths, roiled markets and disrupted countless lives because it was first identified in China in December. Australia is beefing up its potential arsenal against the pandemic to 135 million …
World Diabetes Day: Understanding the importance of safe insulin injection technique Kumar Jeetendra | November 11, 2020 November 11, 2020, New Delhi: . India with an estimated 77 million people living with diabetes is the second most affected country in the world after China1. According to International Diabetes Federation, one in six people in the world with diabetes is from India. The number is projected to grow to become 134 million by …
RheinCell Therapeutics Achieves Milestone GMP Certification to Manufacture Cord Blood-Derived iPSCs for Safe and Compliant Cell Therapies Kumar Jeetendra | January 13, 2021 LANGENFELD, Germany – 13. January 2021 – Life Science Newswire – RheinCell Therapeutics GmbH, a developer and manufacturer of human induced pluripotent stem cells (iPSCs) as starting materials for cell therapies, announced it has received Good Manufacturing Practice (GMP) certification and Manufacturing Authorization. This marks a landmark achievement for RheinCell, which is now among a …
